“Experience in Switching Monoclonal Antibodies in a Patient With Severe Refractory Atopic Dermatitis: From Dupilumab to Abrocitinib. Case Report ”. 2025. Revista Alergia México 72 (4): 382-85. https://doi.org/10.29262/ram.v72i4.1547.